{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:19:30Z","timestamp":1791119970089,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s10072-008-0969-3","type":"journal-article","created":{"date-parts":[[2008,9,19]],"date-time":"2008-09-19T12:59:41Z","timestamp":1221829181000},"page":"205-207","source":"Crossref","is-referenced-by-count":6,"title":["Molecular medicine: predicting and preventing Huntington\u2019s disease"],"prefix":"10.1007","volume":"29","author":[{"given":"Ferdinando","family":"Squitieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Cannella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Frati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,9,20]]},"reference":[{"key":"969_CR1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"J.P. Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ et al (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44:559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"key":"969_CR2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"969_CR3","first-page":"475","volume":"59","author":"C. Gellera","year":"1996","unstructured":"Gellera C, Meoni C, Castellotti B et al (1996) Errors in Huntington disease diagnostic test caused by trinucleotide deletion in the IT15 gene. Am J Hum Genet 59:475\u2013477","journal-title":"Am J Hum Genet"},{"key":"969_CR4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF01995681","volume":"17","author":"F. Squitieri","year":"1996","unstructured":"Squitieri F, Campanella G, Hayden MR (1996) Update on genetics of Huntington\u2019s disease: availability of direct and accurate predictive test. Ital J Neurol Sci 17:185\u2013187","journal-title":"Ital J Neurol Sci"},{"key":"969_CR5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1034\/j.1399-0004.2000.580108.x","volume":"58","author":"F. Squitieri","year":"2000","unstructured":"Squitieri F, Berardelli A, Nargi E et al (2000) Atypical movement disorders in the early stages of Huntington\u2019s disease: clinical and genetic analysis. Clin Genet 58:50\u201356","journal-title":"Clin Genet"},{"key":"969_CR6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/1096-8628(20001211)95:4<366::AID-AJMG13>3.0.CO;2-2","volume":"95","author":"F. Squitieri","year":"2000","unstructured":"Squitieri F, Sabbadini G, Mandich P et al (2000) Family and molecular data for a fine analysis of age at onset in Huntington disease Am J Med Genet 95:366\u2013373","journal-title":"Am J Med Genet"},{"key":"969_CR7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mds.870050202","volume":"5","author":"J.B. Penney Jr","year":"1990","unstructured":"Penney JB Jr, Young AB, Shoulson I et al (1990) Huntington\u2019s disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Mov Disord 5:93\u201399","journal-title":"Mov Disord"},{"key":"969_CR8","first-page":"213","volume":"75","author":"J. Kassubek","year":"2004","unstructured":"Kassubek J, Juengling FD, Kioschies T et al (2004) Topography of cerebral atrophy in early Huntington\u2019s disease: a voxel based morphometric MRI study. J Neurol Neurosurg Psychiatry 75:213\u2013220","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"969_CR9","first-page":"215","volume":"47","author":"A. Ciarmiello","year":"2006","unstructured":"Ciarmiello A, Cannella M, Lastoria S et al (2006) Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington\u2019s disease. J Nucl Med 47:215\u2013222","journal-title":"J Nucl Med"},{"key":"969_CR10","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1212\/01.wnl.0000230149.36635.c8","volume":"67","author":"S.M. Henley","year":"2006","unstructured":"Henley SM, Frost C, MacManus DG et al (2006) Increased rate of whole-brain atrophy over 6 months in early Huntington disease. Neurology 67:694\u2013696","journal-title":"Neurology"},{"key":"969_CR11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/brain\/awn025","volume":"131","author":"H.D. Rosas","year":"2008","unstructured":"Rosas HD, Salat DH, Lee SY et al (2008) Cerebral cortex and the clinical expression of Huntington\u2019s disease: complexity and heterogeneity. Brain 131:1057\u20131068","journal-title":"Brain"},{"key":"969_CR12","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.1073\/pnas.0504921102","volume":"102","author":"F. Borovecki","year":"2005","unstructured":"Borovecki F, Lovrecic L, Zhou J et al (2005) Genome-wide expression profiling of human blood reveals biomarkers for Huntington\u2019s disease. Proc Natl Acad Sci U S A 102:11023\u201311028","journal-title":"Proc Natl Acad Sci U S A"},{"key":"969_CR13","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.neuroimage.2006.05.057","volume":"32","author":"G. Douaud","year":"2006","unstructured":"Douaud G, Gaura V, Ribeiro MJ et al (2006) Distribution of grey matter atrophy in Huntington\u2019s disease patients: a combined ROI-based and voxel-based morphometric study. Neuroimage 32:1562\u20131575","journal-title":"Neuroimage"},{"key":"969_CR14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"M.T. Lin","year":"2006","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787\u2013795","journal-title":"Nature"},{"key":"969_CR15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/01.wnl.0000194318.74946.b6","volume":"66","author":"S.M. Hersch","year":"2006","unstructured":"Hersch SM, Gevorkian S, Marder K et al (2006) Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2\u2019dG. Neurology 66:250\u2013252","journal-title":"Neurology"},{"key":"969_CR16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00259-007-0615-y","volume":"35","author":"F. Squitieri","year":"2008","unstructured":"Squitieri F, Ciammola A, Colonnese C, Ciarmiello A (2008) Neuroprotective effects of riluzole in Huntington\u2019s disease. Eur J Nucl Med Mol Imaging 35:221\u2013222","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"969_CR17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s100720170044","volume":"22","author":"M. Cannella","year":"2001","unstructured":"Cannella M, Simonelli M, D\u2019Alessio C et al (2001) Presymptomatic tests in Huntington\u2019s disease and dominant ataxias. Neurol Sci 22:55\u201356","journal-title":"Neurol Sci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-008-0969-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-008-0969-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-008-0969-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T05:11:37Z","timestamp":1559106697000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-008-0969-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["969"],"URL":"https:\/\/doi.org\/10.1007\/s10072-008-0969-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}